November Meeting
Tue, Nov 16
|Zoom Meeting
Type 2 Diabetes: What's the scientific evidence for the role of the gut microbiome? Presented by Dr. Orville Kolterman and Jennifer McManus, RD, LDN, CDCES Sponsored by: Pendulum Therapeutics
Time & Location
Nov 16, 2021, 6:30 PM
Zoom Meeting
Guests
About the event
An expanding body of evidence demonstrates that pathophysiologic changes occur in the gut microbiome of people with type 2 diabetes. These changes, along with potential management modalities, including the use of novel probiotics, will be discussed. Presenters include a renowned endocrinologist and a registered dietitian nutritionist, certified diabetes care and education specialist well versed in this science. Sufficient time will be allotted for Q and A.
Presenters:
Orville Kolterman, MD
Today Orville Kolterman serves as the chief medical officer of Pendulum Therapeutics. He has been involved in diabetes care for nearly 50 years. He received his MD from University of Chicago and did his endocrinology training at Stanford School of Medicine. Dr. Kolterman is an internationally respected diabetes expert and has successfully brought four glucose-lowering pharmaceuticals from research trials to market. He also served as chief medical officer of Amylin Pharmaceuticals.
Jennifer McManus, RD, LDN, CDCES
Jennifer McManus is one…